Insider · CIK 0002062527
Regan Mills
Files at TER (TERADYNE, INC). First filing Feb 27, 2026, latest Apr 9, 2026.
Regan Mills files SEC Form 4 as president at TER (TERADYNE, INC). Since Feb 27, 2026, Regan Mills has reported 0 open-market buys worth $0 and 3 open-market sells worth $341k, the latest filed on Apr 9, 2026.
A track record needs three past buys with six months of prices behind them; Regan Mills has 0, so none is measured yet.
The newest scored trade: sold $5,475 of TER on Apr 8, 2026, filed Apr 9, 2026, scored 8 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 3 sells worth $341k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TER: TERADYNE, INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 8Weak | TERADYNE, INC | $5,475 16 shares | -0% | +429% from low0% from high | |
| 16Weak | TERADYNE, INC | $73k 252 shares | -2% | +357% from low-10% from high | |
| 21Weak | TERADYNE, INC | $262k 788 shares | -6% | +406% from low0% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Apr 8, 2026 | TER TERADYNE, INC | 16 0.00% of outstanding | $5,475 | Apr 8, 2026 | $336k |
| Apr 2, 2026 | TER TERADYNE, INC | 252 0.00% of outstanding | $73k | Apr 2, 2026 | $262k |
| Feb 25, 2026 | TER TERADYNE, INC | 788 0.00% of outstanding | $262k | Feb 25, 2026 | none |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 8, 2026 | TER TERADYNE, INC | SOpen-market sale Common Stock10b5-1 | -16 | $342.17 | $5,475 | 11,399 | Apr 9, 2026 |
| Apr 1, 2026 | TER TERADYNE, INC | FTax withholding Common Stock10b5-1 | -222 | $312.20 | $69k | 11,667 | Apr 3, 2026 |
| Apr 2, 2026 | TER TERADYNE, INC | SOpen-market sale Common Stock10b5-1 | -252 | $290.88 | $73k | 11,415 | Apr 3, 2026 |
| Feb 25, 2026 | TER TERADYNE, INC | SOpen-market sale Common Stock10b5-1 | -788 | $332.87 | $262k | 11,889 | Feb 27, 2026 |
| Feb 4, 2026 | TER TERADYNE, INC | AGrant or award Common Stock | +1,004 | $0.00 | $0 | 12,677 | Feb 6, 2026 |
| Feb 4, 2026 | TER TERADYNE, INC | AGrant or award Stock Option (Right to Buy)derivative | +886 | $0.00 | $0 | 886 | Feb 6, 2026 |
| Feb 2, 2026 | TER TERADYNE, INC | FTax withholding Common Stock | -345 | $249.53 | $86k | 11,673 | Feb 4, 2026 |
| Jan 27, 2026 | TER TERADYNE, INC | FTax withholding Common Stock | -193 | $238.94 | $46k | 12,185 | Jan 29, 2026 |
| Jan 28, 2026 | TER TERADYNE, INC | FTax withholding Common Stock | -167 | $250.48 | $42k | 12,018 | Jan 29, 2026 |
Questions about Regan Mills
Answered from the filings on this page, as of the latest one.
Is Regan Mills buying or selling?
In the last 12 months Regan Mills reported 0 open-market buys worth $0 and 3 open-market sells worth $341k on SEC Form 4; the latest was sold $5,475 of TER on Apr 8, 2026. Grants, option exercises and tax withholding are not counted.
How did Regan Mills's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Regan Mills has 0.
Where does Regan Mills file Form 4?
Regan Mills has filed Form 4 at TER (TERADYNE, INC) as President, Product Test. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.